Invivyd (IVVD) Gains from Sales and Divestitures (2021 - 2025)
Invivyd (IVVD) reported Gains from Sales and Divestitures of $561000.0 for Q4 2025, little changed quarter-over-quarter from $561000.0 in Q3 2025.
Invivyd (IVVD) Gains from Sales and Divestitures (2021 - 2025) Analysis & Trends
Invivyd has reported Gains from Sales and Divestitures for 4 years, with the latest figure at $561000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Sales and Divestitures changed N/A year-over-year to $561000.0; the trailing twelve-month figure through Dec 2025 stood at $561000.0 (changed N/A YoY), and the FY2025 full-year result was $561000.0, changed N/A from the prior year.
- Gains from Sales and Divestitures for Q4 2025 stood at $561000.0, roughly flat from $561000.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $2.0 million in Q4 2021, with the low at $60055.0 in Q1 2023.
- Historically, Gains from Sales and Divestitures has averaged $644791.0 across 4 years, with a median of $511049.0 in 2022.
- Annual changes were most pronounced in 2022 — Gains from Sales and Divestitures slumped 67.75% — and 2023, when it slumped 86.84%.
- Invivyd's Gains from Sales and Divestitures stood at $2.0 million in 2021, then plunged by 72.04% to $571105.0 in 2022, then slumped by 86.84% to $75166.0 in 2023, then surged by 646.35% to $561000.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $561000.0 (Q4 2025), $561000.0 (Q3 2025), and $75166.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 561,000.00 |
| Dec 31, 2025 | 561,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Dec 31, 2023 | 75,166.00 |
| Dec 31, 2023 | 75,166.00 |
| Sep 30, 2023 | 75,165.00 |
| Sep 30, 2023 | 75,165.00 |
| Jun 30, 2023 | 75,165.00 |
| Jun 30, 2023 | 75,165.00 |
| Mar 31, 2023 | 60,055.00 |
| Mar 31, 2023 | 60,055.00 |
| Dec 31, 2022 | 571,105.00 |
| Dec 31, 2022 | 571,105.00 |
| Sep 30, 2022 | 511,049.00 |
| Sep 30, 2022 | 511,049.00 |
| Jun 30, 2022 | 450,995.00 |
| Jun 30, 2022 | 450,995.00 |
| Mar 31, 2022 | 266,858.00 |
| Mar 31, 2022 | 266,858.00 |